We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ATO:NYSEAtmos Energy Corporation Analysis

Data as of 2026-05-21 - not real-time

$177.46

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Atmos Energy delivered a solid earnings beat this quarter, highlighted by a higher‑than‑expected net income and an upward revision to full‑year earnings guidance. The board also reaffirmed a steady dividend, maintaining the annual payout at four dollars per share, which supports the stock’s appeal to income investors. Technical indicators show the price hovering near a key support level, with the 20‑day moving average just above current trading levels and the RSI edging toward oversold territory, suggesting limited downside risk. However, the MACD remains in bearish territory, indicating that momentum could stay subdued in the near term. Fundamentally, the company trades at a price‑to‑earnings multiple that aligns with its industry peers but is far above the discounted cash‑flow fair value estimate, pointing to a potential overvaluation.
The ultra‑low beta and modest 30‑day volatility underscore the defensive nature of the utility sector, while the increasing volume hints at growing investor interest amid an “extreme greed” market sentiment. Given the high debt load relative to equity, the sustainability of the dividend hinges on continued strong operating cash flow rather than free cash flow generation. Overall, the stock presents a mixed picture: attractive dividend yield and stable regulated earnings offset by valuation pressure and leverage concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near technical support
  • bearish MACD momentum
  • steady dividend payout

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • raised earnings guidance
  • attractive dividend yield
  • increasing trading volume

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • regulated cash‑flow stability
  • high debt‑to‑equity ratio
  • valuation gap to DCF estimate

Key Metrics & Analysis

Financial Health

Revenue Growth0.60%
Profit Margin27.58%
P/E Ratio21.9
ROE9.60%
ROA3.88%
Debt/Equity64.59
P/B Ratio2.0
Op. Cash Flow$1.9B
Free Cash Flow$-2210371840
Industry P/E21.8

Technical Analysis

TrendNeutral
RSI39.1
Support$175.23
Resistance$191.49
MA 20$182.80
MA 50$184.73
MA 200$174.75
MACDBearish
VolumeIncreasing
Fear & Greed Index91.5

Valuation

Fair Value$48.15
Target Price$190.27
Upside/Downside7.22%
GradeOvervalued
TypeValue
Dividend Yield2.27%

Risk Assessment

Beta0.03
Volatility18.51%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.